The DEAD box protein p68: a crucial regulator of AKT/FOXO3a signaling axis in oncogenesis

M Sarkar1, V Khare1, K K N Guturi1

  • 1Cancer Biology and Inflammatory Disorder Division, Council of Scientific and Industrial Research-Indian Institute of Chemical Biology, Kolkata, India.

Oncogene
|March 10, 2015
PubMed

Insights

The DEAD box RNA helicase p68 promotes colon cancer by increasing proto-oncogene AKT and decreasing tumor suppressor FOXO3a. This study reveals p68

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • Proto-oncogene AKT and tumor suppressor FOXO3a play critical roles in cancer.
  • Mechanisms regulating AKT gene expression are not fully understood.
  • DEAD box RNA helicase p68 is a co-activator overexpressed in various cancers.

Purpose of the Study:

  • To elucidate the novel mechanism of p68-mediated transcriptional activation of AKT.
  • To investigate the effect of p68 on FOXO3a expression in colon carcinogenesis.
  • To establish the role of p68 in colon cancer development.

Main Methods:

  • Analysis of p68 and AKT expression correlation in patient samples.
  • In vitro studies using colon cancer cell lines to assess p68's effect on AKT.
  • Chromatin immunoprecipitation to identify p68's binding partners on the AKT promoter.
  • In vivo studies using a mouse colorectal allograft model.

Main Results:

  • p68 expression positively correlates with AKT expression in colon cancer.
  • p68 enhances AKT mRNA, protein levels, and promoter activity.
  • p68 cooperates with β-catenin and NF-κB to activate AKT transcription.
  • p68 reduces FOXO3a protein levels in an AKT-dependent manner.
  • In vivo studies confirm p68's role in promoting tumor growth and metastasis.

Conclusions:

  • p68 acts as a transcriptional activator of AKT in colon cancer.
  • p68 upregulates AKT, leading to decreased FOXO3a levels and promoting oncogenesis.
  • This study uncovers a new mechanism of cancer development driven by p68.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
8.0K